Clinical Trial Update: Expanded Access of Vigil in Solid Tumors

View source ↗

Summary

The expanded access program for Vigil in solid tumors, including Ewing sarcoma, is temporarily not available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ewing Sarcoma
• Gynecologic Cancer
• Ovarian Cancer
• Solid Tumors
• Uterine Cancer

Drugs mentioned

• Vigil

Snippet

Sponsor: Gradalis, Inc. | Conditions: Solid Tumor, Ewing Sarcoma | Status: TEMPORARILY_NOT_AVAILABLE